Intellia Therapeutics spent some 466 million U.S. dollars on research and development in 2024, compared to 11 million U.S. dollars back in 2015. Intellia is a biotech company from Massachusetts that produces therapeutics using CRISPR technology.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Intellia Therapeutics, & U.S. Securities and Exchange Commission. (February 27, 2025). Research and development expenses of Intellia Therapeutics from 2014 to 2024 (in million U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 26, 2026, from /statistics/1097423/research-and-development-costs-for-intellia-therapeutics/
Intellia Therapeutics, und U.S. Securities and Exchange Commission. "Research and development expenses of Intellia Therapeutics from 2014 to 2024 (in million U.S. dollars)." Chart. February 27, 2025. ÌÇÐÄÆƽâ°æ. Accessed July 26, 2026. /statistics/1097423/research-and-development-costs-for-intellia-therapeutics/
Intellia Therapeutics, U.S. Securities and Exchange Commission. (2025). Research and development expenses of Intellia Therapeutics from 2014 to 2024 (in million U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 26, 2026. /statistics/1097423/research-and-development-costs-for-intellia-therapeutics/
Intellia Therapeutics, and U.S. Securities and Exchange Commission. "Research and Development Expenses of Intellia Therapeutics from 2014 to 2024 (in Million U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 27 Feb 2025, /statistics/1097423/research-and-development-costs-for-intellia-therapeutics/
Intellia Therapeutics & U.S. Securities and Exchange Commission, Research and development expenses of Intellia Therapeutics from 2014 to 2024 (in million U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/1097423/research-and-development-costs-for-intellia-therapeutics/ (last visited July 26, 2026)
Research and development expenses of Intellia Therapeutics from 2014 to 2024 (in million U.S. dollars) [Graph], Intellia Therapeutics, & U.S. Securities and Exchange Commission, February 27, 2025. [Online]. Available: /statistics/1097423/research-and-development-costs-for-intellia-therapeutics/
